Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1544-1545

  Burke, G W ^a   Ciancio, G ^a   Alejandro, R ^b   Roth, D ^b   Ricordi, C ^a   Tzakis, A ^a   Miller, J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS;

ADULT; ANTIBODY RESPONSE; CLINICAL ARTICLE; CONFERENCE PAPER; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; METHYLPREDNISOLONE HEMISUCCINATE; MUROMONAB-CD3; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; TACROLIMUS;

EID: 0031803570     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00350-9     Document Type: Conference Paper

References (3)

1. Burke GW, Alejandro R, Ciancio G, et al: Transplant Proc 27:3123, 1995
2. Stratta RJ, et al: Transplant Proc 29:654, 1997
3. Burke GW, Ricordi C, Karatzas T, et al: Transplant Proc 29:1207, 1997